Cardiac Stem Cell Therapy for Cardiac Repair
Open Access
- 7 June 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Treatment Options in Cardiovascular Medicine
- Vol. 16 (7), 1-19
- https://doi.org/10.1007/s11936-014-0324-3
Abstract
The discovery of adult cardiac stem cells (CSCs) and their potential to restore functional cardiac tissue has fueled unprecedented interest in recent years. Indeed, stem-cell–based therapies have the potential to transform the treatment and prognosis of heart failure, for they have the potential to eliminate the underlying cause of the disease by reconstituting the damaged heart with functional cardiac cells. Over the last decade, several independent laboratories have demonstrated the utility of c-kit+/Lin- resident CSCs in alleviating left ventricular dysfunction and remodeling in animal models of acute and chronic myocardial infarction. Recently, the first clinical trial of autologous CSCs for treatment of heart failure resulting from ischemic heart disease (Stem Cell Infusion in Patients with Ischemic cardiOmyopathy [SCIPIO]) has been conducted, and the interim results are quite promising. In this phase I trial, no adverse effects attributable to the CSC treatment have been noted, and CSC-treated patients showed a significant improvement in ejection fraction at 1 year (+13.7 absolute units versus baseline), accompanied by a 30.2 % reduction in infarct size. Moreover, the CSC-induced enhancement in cardiac structure and function was associated with a significant improvement in the New York Heart Association (NYHA) functional class and in the quality of life, as measured by the Minnesota Living with Heart failure Questionnaire. These results are exciting and warrant larger, phase II studies. However, CSC therapy for cardiac repair is still in its infancy, and many hurdles need to be overcome to further enhance the therapeutic efficacy of CSCs.Keywords
This publication has 99 references indexed in Scilit:
- Protein O-GlcNAcylation Is a Novel Cytoprotective Signal in Cardiac Stem CellsThe International Journal of Cell Cloning, 2013
- Increased Mitotic Rate Coincident with Transient Telomere Lengthening Resulting from Pim‐1 Overexpression in Cardiac Progenitor CellsThe International Journal of Cell Cloning, 2012
- Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialThe Lancet, 2011
- Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial OriginCell Stem Cell, 2011
- Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine modelsBasic Research in Cardiology, 2011
- Paracrine mechanisms of stem cell reparative and regenerative actions in the heartJournal of Molecular and Cellular Cardiology, 2011
- Guided Cardiopoiesis Enhances Therapeutic Benefit of Bone Marrow Human Mesenchymal Stem Cells in Chronic Myocardial InfarctionJournal of Invasive Cardiology, 2010
- Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantationJournal of Molecular and Cellular Cardiology, 2008
- Systems approaches to preventing transplanted cell death in cardiac repairJournal of Molecular and Cellular Cardiology, 2008
- Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injuryNature Medicine, 2007